激素相关基因中的遗传变异与乳腺癌风险。
Genetic variants in hormone-related genes and risk of breast cancer.
机构信息
Department of Population Health, New York University School of Medicine, New York, New York, United States of America.
出版信息
PLoS One. 2013 Jul 23;8(7):e69367. doi: 10.1371/journal.pone.0069367. Print 2013.
Abstract
Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs and repeat polymorphisms) in hormone-related genes are associated with sex hormone levels. However, the relationship observed between these genetic variants and breast cancer risk has been inconsistent. We conducted a case-control study nested within two prospective cohorts to assess the relationship between specific genetic variants in hormone-related genes and breast cancer risk. In total, 1164 cases and 2111 individually-matched controls were included in the study. We did not observe an association between potential functional genetic polymorphisms in the estrogen pathway, SHBG rs6259, ESR1 rs2234693, CYP19 rs10046 and rs4775936, and UGT1A1 rs8175347, or the progesterone pathway, PGR rs1042838, with the risk of breast cancer. Our results suggest that these genetic variants do not have a strong effect on breast cancer risk.
摘要
性激素在乳腺癌的发展中起着关键作用。与激素相关的基因中的某些多态性变异（SNP 和重复多态性）与性激素水平有关。然而，观察到这些遗传变异与乳腺癌风险之间的关系并不一致。我们进行了一项病例对照研究，该研究嵌套在两个前瞻性队列中，以评估与激素相关基因中的特定遗传变异与乳腺癌风险之间的关系。共有 1164 例病例和 2111 例个体匹配对照纳入了该研究。我们没有观察到雌激素途径中的潜在功能性遗传多态性、SHBG rs6259、ESR1 rs2234693、CYP19 rs10046 和 rs4775936 以及 UGT1A1 rs8175347，或孕激素途径中的 PGR rs1042838 与乳腺癌风险之间存在关联。我们的结果表明，这些遗传变异对乳腺癌风险的影响不大。
相似文献
1
Genetic variants in hormone-related genes and risk of breast cancer.激素相关基因中的遗传变异与乳腺癌风险。
PLoS One. 2013 Jul 23;8(7):e69367. doi: 10.1371/journal.pone.0069367. Print 2013.
2
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.性激素相关基因、循环性激素的选择多态性与子宫内膜癌风险。
Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.
3
Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3).绝经前后妇女乳腺癌和前列腺癌队列联盟（BPC3）中与类固醇激素代谢相关的 36 个基因的激素和遗传变异综合分析。
J Clin Endocrinol Metab. 2011 Feb;96(2):E360-7. doi: 10.1210/jc.2010-0912. Epub 2010 Dec 22.
4
Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.雌激素和孕激素通路基因的遗传变异与乳腺癌风险：肿瘤亚型特异性效应的探索。
Cancer Causes Control. 2015 Jan;26(1):121-31. doi: 10.1007/s10552-014-0491-2. Epub 2014 Nov 25.
5
Polymorphisms associated with circulating sex hormone levels in postmenopausal women.绝经后女性中与循环性激素水平相关的多态性
J Natl Cancer Inst. 2004 Jun 16;96(12):936-45. doi: 10.1093/jnci/djh167.
6
Polymorphisms in steroid hormone pathway genes and mammographic density.类固醇激素通路基因多态性与乳腺X线密度
Breast Cancer Res Treat. 2003 Jan;77(1):27-36. doi: 10.1023/a:1021112121782.
7
The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.激素代谢途径基因多态性、绝经激素治疗与乳腺癌风险的关联：加利福尼亚教师研究队列中的巢式病例对照研究。
Breast Cancer Res. 2011 Apr 1;13(2):R37. doi: 10.1186/bcr2859.
8
Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.孕激素受体（PGR）基因变异与乳腺癌及其相关特征的关系：一项病例对照研究。
Pathol Oncol Res. 2020 Jan;26(1):141-147. doi: 10.1007/s12253-017-0379-z. Epub 2018 Jan 4.
9
Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.在日本人群、日裔巴西人以及非日裔巴西人的病例对照研究中，膳食异黄酮摄入量、CYP17、CYP19、17β-HSD1和SHBG基因多态性与乳腺癌风险的关系
Nutr Cancer. 2010;62(4):466-75. doi: 10.1080/01635580903441279.
10
Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.常见 miRNA 生物发生途径基因的遗传多态性与乳腺癌风险：韩国的病例对照研究。
Breast Cancer Res Treat. 2011 Dec;130(3):939-51. doi: 10.1007/s10549-011-1656-2. Epub 2011 Jul 16.
引用本文的文献
1
Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.孕激素受体基因多态性与乳腺癌风险。
Endocrinology. 2023 Feb 11;164(4). doi: 10.1210/endocr/bqad020.
2
Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.PROGINS PgR 多态性与女性生殖系统癌症易感性的关联：30 项研究的荟萃分析。
PLoS One. 2022 Jul 15;17(7):e0271265. doi: 10.1371/journal.pone.0271265. eCollection 2022.
3
Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon.基因多态性可作为肺癌的危险因素：来自亚马逊地区患者的初步研究。
Genes (Basel). 2022 Mar 11;13(3):493. doi: 10.3390/genes13030493.
4
Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.雌激素受体 1 基因（ESR1）rs2234693 多态性与沙特女性乳腺癌风险的关系。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3235-3240. doi: 10.31557/APJCP.2020.21.11.3235.
5
Circulating unmetabolized folic acid and 5-methyltetrahydrofolate and risk of breast cancer: a nested case-control study.循环未代谢的叶酸和 5-甲基四氢叶酸与乳腺癌风险：一项巢式病例对照研究。
Eur J Clin Nutr. 2020 Sep;74(9):1306-1315. doi: 10.1038/s41430-020-0615-6. Epub 2020 Apr 21.
6
Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.芳香化酶（CYP19A1）表达升高与雌激素受体阳性乳腺癌患者的生存预后不良相关。
Horm Cancer. 2018 Apr;9(2):128-138. doi: 10.1007/s12672-017-0317-2. Epub 2018 Jan 23.
7
Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.孕激素受体（PGR）基因变异与乳腺癌及其相关特征的关系：一项病例对照研究。
Pathol Oncol Res. 2020 Jan;26(1):141-147. doi: 10.1007/s12253-017-0379-z. Epub 2018 Jan 4.
8
Association of three single nucleotide polymorphisms of ESR1with breast cancer susceptibility: a meta-analysis.雌激素受体1的三个单核苷酸多态性与乳腺癌易感性的关联：一项荟萃分析。
J Biomed Res. 2017 Jan 19;31(3):213-225. doi: 10.7555/JBR.31.20160087.
9
Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms.人肝脏和乳腺中双酚A的葡萄糖醛酸化：尿苷二磷酸葡萄糖醛酸基转移酶（UGTs）的鉴定及基因多态性的影响
Xenobiotica. 2017 Jan;47(1):1-10. doi: 10.3109/00498254.2016.1156784. Epub 2016 Mar 21.
10
Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology.使用Sequenom MassARRAY技术对从血清中分离的DNA进行单核苷酸多态性基因分型。
PLoS One. 2015 Aug 14;10(8):e0135943. doi: 10.1371/journal.pone.0135943. eCollection 2015.
本文引用的文献
1
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.CYP19 基因 rs10046 多态性与乳腺癌风险的关联：从病例对照研究到 20098 例的荟萃分析。
PLoS One. 2013;8(1):e53902. doi: 10.1371/journal.pone.0053902. Epub 2013 Jan 16.
2
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).亚洲和欧洲全基因组关联研究在乳腺癌协会联盟（BCAC）中对 6q25 乳腺癌命中的比较。
PLoS One. 2012;7(8):e42380. doi: 10.1371/journal.pone.0042380. Epub 2012 Aug 7.
3
Association between SHBG Asp327Asn (rs6259) polymorphism and breast cancer risk: a meta-analysis of 10,454 cases and 13,111 controls.SHBG Asp327Asn（rs6259）多态性与乳腺癌风险的关联：一项包含 10454 例病例和 13111 例对照的荟萃分析。
Mol Biol Rep. 2012 Aug;39(8):8307-14. doi: 10.1007/s11033-012-1680-2. Epub 2012 Jun 19.
4
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.性激素相关基因、循环性激素的选择多态性与子宫内膜癌风险。
Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.
5
CYP3A variation, premenopausal estrone levels, and breast cancer risk.CYP3A 变异、绝经前雌酮水平与乳腺癌风险。
J Natl Cancer Inst. 2012 May 2;104(9):657-69. doi: 10.1093/jnci/djs156. Epub 2012 Apr 3.
6
Common breast cancer susceptibility loci are associated with triple-negative breast cancer.常见的乳腺癌易感基因座与三阴性乳腺癌相关。
Cancer Res. 2011 Oct 1;71(19):6240-9. doi: 10.1158/0008-5472.CAN-11-1266. Epub 2011 Aug 15.
7
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.位于 6q25.1 和 1p11.2 的常见等位基因与 BRCA1 和 BRCA2 基因突变携带者的乳腺癌风险相关。
Hum Mol Genet. 2011 Aug 15;20(16):3304-21. doi: 10.1093/hmg/ddr226. Epub 2011 May 18.
8
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.与乳腺癌风险相关的遗传变异：综合研究综述、荟萃分析和流行病学证据。
Lancet Oncol. 2011 May;12(5):477-88. doi: 10.1016/S1470-2045(11)70076-6. Epub 2011 Apr 20.
9
Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women.内源性雌激素与绝经前和绝经后妇女的乳腺癌风险。
Steroids. 2011 Jul;76(8):812-5. doi: 10.1016/j.steroids.2011.02.029. Epub 2011 Apr 6.
10
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.6q25.1 乳腺癌易感位点的复制和功能基因组分析表明其在中国、日本和欧洲裔女性中的重要性。
Cancer Res. 2011 Feb 15;71(4):1344-55. doi: 10.1158/0008-5472.CAN-10-2733. Epub 2011 Feb 8.
Zotero 插件